SCHEMBL5083455

SCHEMBL5083455

Nc1nc(-c2ccc3ccc(Nc4ccccc4)nc3c2F)cn2c(C3CC(O)C3)ncc12

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DHFR P00374 2/20 0.34
IGF1R P08069 15/20 0.34
PIM1 P11309 3/20 0.33
PIM2 Q9P1W9 2/20 0.33
INSR P06213 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5085504 0.88 IGF1R (0.34) IGF1R
SCHEMBL5082570 0.83 TNK2 (0.39) IGF1RINSR
SCHEMBL5080364 0.81 IGF1R (0.36) IGF1RINSR
SCHEMBL399465 0.76 IGF1R (0.57) IGF1R
SCHEMBL399321 0.71 EGFR (0.59) IGF1RINSR
SCHEMBL5083797 0.69 IGF1R (0.38) IGF1RINSR
SCHEMBL5087010 0.69 IGF1R (0.39) IGF1R
SCHEMBL5080636 0.68 IGF1R (0.48) IGF1R
SCHEMBL4356352 0.68 GSK3B (0.41) IGF1RINSR
SCHEMBL5085414 0.67 TNK2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008076143-A1 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2008-06-26 WO claimed